nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinonide—SMO—Hedgehog signaling events mediated by Gli proteins—IFT88—liver cancer	0.0788	0.103	CbGpPWpGaD
Fluocinonide—SMO—Hedgehog 'off' state—IFT88—liver cancer	0.0445	0.058	CbGpPWpGaD
Fluocinonide—SMO—Hair Follicle Development: Induction (Part 1 of 3)—FST—liver cancer	0.0417	0.0544	CbGpPWpGaD
Fluocinonide—SMO—Signaling by Hedgehog—IFT88—liver cancer	0.0397	0.0518	CbGpPWpGaD
Fluocinonide—Folliculitis—Sorafenib—liver cancer	0.0178	0.0766	CcSEcCtD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—TAT—liver cancer	0.0177	0.0231	CbGpPWpGaD
Fluocinonide—SMO—Hedgehog 'off' state—PSMA4—liver cancer	0.0144	0.0188	CbGpPWpGaD
Fluocinonide—SMO—Hedgehog 'off' state—PSMD10—liver cancer	0.0144	0.0188	CbGpPWpGaD
Fluocinonide—Secondary infection—Epirubicin—liver cancer	0.0141	0.0606	CcSEcCtD
Fluocinonide—SMO—Signaling by Hedgehog—ADAM17—liver cancer	0.0137	0.0178	CbGpPWpGaD
Fluocinonide—Secondary infection—Doxorubicin—liver cancer	0.013	0.0561	CcSEcCtD
Fluocinonide—SMO—Signaling by Hedgehog—PSMD10—liver cancer	0.0129	0.0168	CbGpPWpGaD
Fluocinonide—SMO—Signaling by Hedgehog—PSMA4—liver cancer	0.0129	0.0168	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptors—NR1I3—liver cancer	0.0128	0.0167	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—FST—liver cancer	0.0124	0.0162	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—CPT1B—liver cancer	0.012	0.0157	CbGpPWpGaD
Fluocinonide—SMO—Signaling events mediated by the Hedgehog family—PIK3CA—liver cancer	0.011	0.0144	CbGpPWpGaD
Fluocinonide—Skin exfoliation—Sorafenib—liver cancer	0.0107	0.046	CcSEcCtD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—NR1H4—liver cancer	0.0103	0.0134	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—NR1I3—liver cancer	0.0101	0.0132	CbGpPWpGaD
Fluocinonide—SMO—Hair Follicle Development: Induction (Part 1 of 3)—CTNNB1—liver cancer	0.00992	0.0129	CbGpPWpGaD
Fluocinonide—Leukoderma—Epirubicin—liver cancer	0.00975	0.0419	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—HNF4A—liver cancer	0.00967	0.0126	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—HPGDS—liver cancer	0.00948	0.0124	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALDOB—liver cancer	0.00929	0.0121	CbGpPWpGaD
Fluocinonide—SMO—Signaling events mediated by the Hedgehog family—AKT1—liver cancer	0.00902	0.0118	CbGpPWpGaD
Fluocinonide—Leukoderma—Doxorubicin—liver cancer	0.00902	0.0388	CcSEcCtD
Fluocinonide—NR3C1—Nuclear Receptors—HNF4A—liver cancer	0.00889	0.0116	CbGpPWpGaD
Fluocinonide—SMO—Hair Follicle Development: Induction (Part 1 of 3)—MYC—liver cancer	0.00804	0.0105	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—HNF4A—liver cancer	0.0079	0.0103	CbGpPWpGaD
Fluocinonide—Dry skin—Sorafenib—liver cancer	0.00746	0.0321	CcSEcCtD
Fluocinonide—Nasopharyngitis—Sorafenib—liver cancer	0.00728	0.0313	CcSEcCtD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—HNF4A—liver cancer	0.00702	0.00915	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—NR1I3—liver cancer	0.00693	0.00903	CbGpPWpGaD
Fluocinonide—Eruption—Epirubicin—liver cancer	0.00674	0.0289	CcSEcCtD
Fluocinonide—Folliculitis—Epirubicin—liver cancer	0.00659	0.0283	CcSEcCtD
Fluocinonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—liver cancer	0.00654	0.00853	CbGpPWpGaD
Fluocinonide—Eruption—Doxorubicin—liver cancer	0.00623	0.0268	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	0.00623	0.00812	CbGpPWpGaD
Fluocinonide—Folliculitis—Doxorubicin—liver cancer	0.0061	0.0262	CcSEcCtD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—liver cancer	0.00597	0.00779	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CCR4—liver cancer	0.00583	0.0076	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—SCD—liver cancer	0.00578	0.00754	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—ATF3—liver cancer	0.00564	0.00736	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	0.00534	0.00696	CbGpPWpGaD
Fluocinonide—Glycosuria—Epirubicin—liver cancer	0.00511	0.022	CcSEcCtD
Fluocinonide—Immune system disorder—Sorafenib—liver cancer	0.00509	0.0219	CcSEcCtD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—liver cancer	0.00502	0.00655	CbGpPWpGaD
Fluocinonide—SMO—Hedgehog signaling events mediated by Gli proteins—AKT1—liver cancer	0.00501	0.00653	CbGpPWpGaD
Fluocinonide—Erythema—Sorafenib—liver cancer	0.0049	0.0211	CcSEcCtD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—HNF4A—liver cancer	0.00485	0.00632	CbGpPWpGaD
Fluocinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—liver cancer	0.00477	0.00622	CbGpPWpGaD
Fluocinonide—Glycosuria—Doxorubicin—liver cancer	0.00473	0.0203	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.00469	0.00611	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptors—PPARA—liver cancer	0.00467	0.00608	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	0.0046	0.00599	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CHN2—liver cancer	0.00444	0.00579	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.00435	0.00567	CbGpPWpGaD
Fluocinonide—NR3C1—Signaling events mediated by HDAC Class II—ESR1—liver cancer	0.00423	0.00551	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptors—ESR1—liver cancer	0.00423	0.00551	CbGpPWpGaD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00414	0.0178	CcSEcCtD
Fluocinonide—Dermatitis contact—Epirubicin—liver cancer	0.00409	0.0176	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—IFT88—liver cancer	0.00406	0.00529	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—liver cancer	0.00401	0.00523	CbGpPWpGaD
Fluocinonide—Infection—Sorafenib—liver cancer	0.00397	0.0171	CcSEcCtD
Fluocinonide—Skin exfoliation—Epirubicin—liver cancer	0.00396	0.017	CcSEcCtD
Fluocinonide—Nervous system disorder—Sorafenib—liver cancer	0.00392	0.0169	CcSEcCtD
Fluocinonide—Skin disorder—Sorafenib—liver cancer	0.00389	0.0167	CcSEcCtD
Fluocinonide—NR3C1—Nuclear Receptors—PPARG—liver cancer	0.00386	0.00503	CbGpPWpGaD
Fluocinonide—Dermatitis contact—Doxorubicin—liver cancer	0.00379	0.0163	CcSEcCtD
Fluocinonide—NR3C1—Adipogenesis—AHR—liver cancer	0.00373	0.00486	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—liver cancer	0.00372	0.00484	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—PPARA—liver cancer	0.00369	0.00481	CbGpPWpGaD
Fluocinonide—Skin exfoliation—Doxorubicin—liver cancer	0.00366	0.0157	CcSEcCtD
Fluocinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—liver cancer	0.00355	0.00463	CbGpPWpGaD
Fluocinonide—NR3C1—Circadian Clock—PPARA—liver cancer	0.00347	0.00453	CbGpPWpGaD
Fluocinonide—Pain—Sorafenib—liver cancer	0.00342	0.0147	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.00341	0.00445	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—ESR1—liver cancer	0.00334	0.00436	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—MAPK14—liver cancer	0.0033	0.00431	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CSF2—liver cancer	0.00327	0.00426	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—liver cancer	0.00317	0.00414	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.00313	0.00408	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—TRIO—liver cancer	0.00312	0.00407	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—liver cancer	0.00309	0.00402	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.00306	0.00399	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—liver cancer	0.00305	0.00397	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCR4—liver cancer	0.00299	0.0039	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	0.00298	0.00389	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	0.00298	0.00388	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	0.00295	0.00385	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Sorafenib—liver cancer	0.00295	0.0127	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	0.00289	0.00376	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—CSF2—liver cancer	0.00288	0.00375	CbGpPWpGaD
Fluocinonide—Pruritus—Sorafenib—liver cancer	0.00283	0.0122	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	0.00282	0.00367	CbGpPWpGaD
Fluocinonide—Dry skin—Epirubicin—liver cancer	0.00276	0.0118	CcSEcCtD
Fluocinonide—Nasopharyngitis—Epirubicin—liver cancer	0.00269	0.0116	CcSEcCtD
Fluocinonide—Dizziness—Sorafenib—liver cancer	0.00264	0.0114	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	0.0026	0.00339	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—ESR1—liver cancer	0.00259	0.00338	CbGpPWpGaD
Fluocinonide—NR3C1—Circadian Clock—SERPINE1—liver cancer	0.00259	0.00337	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—liver cancer	0.00256	0.00334	CbGpPWpGaD
Fluocinonide—Dry skin—Doxorubicin—liver cancer	0.00255	0.011	CcSEcCtD
Fluocinonide—Rash—Sorafenib—liver cancer	0.00252	0.0108	CcSEcCtD
Fluocinonide—Dermatitis—Sorafenib—liver cancer	0.00252	0.0108	CcSEcCtD
Fluocinonide—NR3C1—Endoderm Differentiation—APC—liver cancer	0.00251	0.00327	CbGpPWpGaD
Fluocinonide—Headache—Sorafenib—liver cancer	0.00251	0.0108	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—SHC3—liver cancer	0.00249	0.00324	CbGpPWpGaD
Fluocinonide—Nasopharyngitis—Doxorubicin—liver cancer	0.00249	0.0107	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	0.00239	0.00312	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	0.00239	0.00311	CbGpPWpGaD
Fluocinonide—Hyperglycaemia—Epirubicin—liver cancer	0.00234	0.0101	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—F2—liver cancer	0.00233	0.00304	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK14—liver cancer	0.00233	0.00304	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—liver cancer	0.00231	0.00301	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	0.00223	0.0029	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	0.00221	0.00288	CbGpPWpGaD
Fluocinonide—Hyperglycaemia—Doxorubicin—liver cancer	0.00217	0.00932	CcSEcCtD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—JUN—liver cancer	0.0021	0.00273	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	0.00203	0.00265	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CDKN2A—liver cancer	0.00199	0.0026	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—MAPK8—liver cancer	0.00198	0.00259	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	0.00196	0.00256	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FST—liver cancer	0.00193	0.00252	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—liver cancer	0.0019	0.00247	CbGpPWpGaD
Fluocinonide—Immune system disorder—Epirubicin—liver cancer	0.00188	0.00808	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—TRIO—liver cancer	0.00184	0.0024	CbGpPWpGaD
Fluocinonide—Erythema—Epirubicin—liver cancer	0.00181	0.00778	CcSEcCtD
Fluocinonide—NR3C1—Generic Transcription Pathway—NR1H4—liver cancer	0.00178	0.00232	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCR4—liver cancer	0.00177	0.0023	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CDKN1B—liver cancer	0.00176	0.0023	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—NR1I3—liver cancer	0.00175	0.00228	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—PPARA—liver cancer	0.00175	0.00227	CbGpPWpGaD
Fluocinonide—Immune system disorder—Doxorubicin—liver cancer	0.00174	0.00747	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—IL2—liver cancer	0.00173	0.00225	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PRKCE—liver cancer	0.00172	0.00225	CbGpPWpGaD
Fluocinonide—NR3C1—Endoderm Differentiation—CTNNB1—liver cancer	0.00171	0.00222	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CCND1—liver cancer	0.00168	0.00219	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—JUN—liver cancer	0.00168	0.00219	CbGpPWpGaD
Fluocinonide—Erythema—Doxorubicin—liver cancer	0.00168	0.0072	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—CTNNB1—liver cancer	0.00167	0.00217	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	0.00166	0.00216	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—MMP9—liver cancer	0.00163	0.00213	CbGpPWpGaD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00153	0.00658	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—CSF2—liver cancer	0.00152	0.00199	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—liver cancer	0.00152	0.00198	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—liver cancer	0.00149	0.00195	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—JUN—liver cancer	0.00148	0.00193	CbGpPWpGaD
Fluocinonide—Infection—Epirubicin—liver cancer	0.00147	0.00631	CcSEcCtD
Fluocinonide—Nervous system disorder—Epirubicin—liver cancer	0.00145	0.00623	CcSEcCtD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—liver cancer	0.00145	0.00189	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—PPARG—liver cancer	0.00144	0.00188	CbGpPWpGaD
Fluocinonide—Skin disorder—Epirubicin—liver cancer	0.00144	0.00617	CcSEcCtD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—liver cancer	0.00143	0.00187	CbGpPWpGaD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00142	0.00609	CcSEcCtD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—liver cancer	0.0014	0.00182	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ADAM17—liver cancer	0.0014	0.00182	CbGpPWpGaD
Fluocinonide—NR3C1—Endoderm Differentiation—TGFB1—liver cancer	0.00138	0.0018	CbGpPWpGaD
Fluocinonide—Infection—Doxorubicin—liver cancer	0.00136	0.00584	CcSEcCtD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—liver cancer	0.00136	0.00177	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—MYC—liver cancer	0.00135	0.00176	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—TGFB1—liver cancer	0.00135	0.00175	CbGpPWpGaD
Fluocinonide—Nervous system disorder—Doxorubicin—liver cancer	0.00134	0.00576	CcSEcCtD
Fluocinonide—Skin disorder—Doxorubicin—liver cancer	0.00133	0.00571	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—PSMA4—liver cancer	0.00131	0.00171	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PSMD10—liver cancer	0.00131	0.00171	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—SERPINE1—liver cancer	0.0013	0.00169	CbGpPWpGaD
Fluocinonide—Pain—Epirubicin—liver cancer	0.00126	0.00543	CcSEcCtD
Fluocinonide—NR3C1—Generic Transcription Pathway—HNF4A—liver cancer	0.00121	0.00158	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—liver cancer	0.0012	0.00156	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—F2—liver cancer	0.0012	0.00156	CbGpPWpGaD
Fluocinonide—Pain—Doxorubicin—liver cancer	0.00117	0.00503	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—PIK3CG—liver cancer	0.00114	0.00149	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—TP53—liver cancer	0.00111	0.00144	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Epirubicin—liver cancer	0.00109	0.00468	CcSEcCtD
Fluocinonide—NR3C1—Gene Expression—EXOSC2—liver cancer	0.00108	0.0014	CbGpPWpGaD
Fluocinonide—Pruritus—Epirubicin—liver cancer	0.00105	0.00449	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—PRKCE—liver cancer	0.00102	0.00133	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—CTNNB1—liver cancer	0.00102	0.00132	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—IL6—liver cancer	0.00101	0.00132	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Doxorubicin—liver cancer	0.00101	0.00433	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—PIK3CD—liver cancer	0.00101	0.00131	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—CDKN1A—liver cancer	0.000992	0.00129	CbGpPWpGaD
Fluocinonide—Dizziness—Epirubicin—liver cancer	0.000978	0.0042	CcSEcCtD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—liver cancer	0.000976	0.00127	CbGpPWpGaD
Fluocinonide—Pruritus—Doxorubicin—liver cancer	0.000968	0.00416	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—IGF2—liver cancer	0.000964	0.00126	CbGpPWpGaD
Fluocinonide—Rash—Epirubicin—liver cancer	0.000932	0.00401	CcSEcCtD
Fluocinonide—Dermatitis—Epirubicin—liver cancer	0.000931	0.004	CcSEcCtD
Fluocinonide—Headache—Epirubicin—liver cancer	0.000926	0.00398	CcSEcCtD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CASP3—liver cancer	0.00091	0.00119	CbGpPWpGaD
Fluocinonide—Dizziness—Doxorubicin—liver cancer	0.000904	0.00389	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—CSF2—liver cancer	0.0009	0.00117	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—RAF1—liver cancer	0.000898	0.00117	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—liver cancer	0.000894	0.00116	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—H2AFX—liver cancer	0.000887	0.00116	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—STAT3—liver cancer	0.000885	0.00115	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—JUN—liver cancer	0.000884	0.00115	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.000877	0.00114	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PIK3CB—liver cancer	0.000877	0.00114	CbGpPWpGaD
Fluocinonide—Rash—Doxorubicin—liver cancer	0.000862	0.00371	CcSEcCtD
Fluocinonide—Dermatitis—Doxorubicin—liver cancer	0.000862	0.0037	CcSEcCtD
Fluocinonide—NR3C1—Gene Expression—NR1H4—liver cancer	0.000857	0.00112	CbGpPWpGaD
Fluocinonide—Headache—Doxorubicin—liver cancer	0.000857	0.00368	CcSEcCtD
Fluocinonide—NR3C1—Gene Expression—NR1I3—liver cancer	0.000843	0.0011	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—liver cancer	0.000833	0.00109	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—liver cancer	0.000825	0.00107	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—TGFB1—liver cancer	0.00082	0.00107	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—IL2—liver cancer	0.000805	0.00105	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TERT—liver cancer	0.000803	0.00105	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.000772	0.00101	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—TNF—liver cancer	0.000766	0.000998	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—KDR—liver cancer	0.000734	0.000957	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MAPK14—liver cancer	0.000729	0.00095	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ESR1—liver cancer	0.000715	0.000932	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—F2—liver cancer	0.000707	0.000921	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PIK3CG—liver cancer	0.000676	0.000881	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—APC—liver cancer	0.000676	0.000881	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—TNF—liver cancer	0.000662	0.000863	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—PPARA—liver cancer	0.000637	0.00083	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—BRAF—liver cancer	0.000636	0.000828	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—IL6—liver cancer	0.000618	0.000806	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PIK3CD—liver cancer	0.000594	0.000775	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SERPINE1—liver cancer	0.000588	0.000766	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—HNF4A—liver cancer	0.000584	0.000761	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—KRAS—liver cancer	0.000582	0.000758	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—ESR1—liver cancer	0.000577	0.000752	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PIK3CA—liver cancer	0.000535	0.000697	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL6—liver cancer	0.000534	0.000696	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—RAF1—liver cancer	0.000531	0.000692	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—PPARG—liver cancer	0.000527	0.000686	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MTOR—liver cancer	0.000518	0.000675	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PIK3CB—liver cancer	0.000518	0.000675	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—PSMD10—liver cancer	0.00051	0.000665	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—PSMA4—liver cancer	0.00051	0.000665	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—HRAS—liver cancer	0.000495	0.000645	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CDKN1B—liver cancer	0.000486	0.000634	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CASP3—liver cancer	0.000477	0.000621	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IL2—liver cancer	0.000476	0.00062	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—SERPINE1—liver cancer	0.000474	0.000618	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—IL6—liver cancer	0.000473	0.000617	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCND1—liver cancer	0.000464	0.000605	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—JUN—liver cancer	0.000463	0.000603	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CTNNB1—liver cancer	0.000459	0.000599	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MMP9—liver cancer	0.00045	0.000587	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CDKN1A—liver cancer	0.000449	0.000585	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MAPK8—liver cancer	0.000438	0.000571	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—AKT1—liver cancer	0.000437	0.000569	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—VEGFA—liver cancer	0.000404	0.000527	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—STAT3—liver cancer	0.0004	0.000522	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MYC—liver cancer	0.000372	0.000485	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TGFB1—liver cancer	0.000371	0.000484	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—H2AFX—liver cancer	0.000345	0.000449	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—KRAS—liver cancer	0.000344	0.000448	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PIK3CA—liver cancer	0.000316	0.000412	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—PPARA—liver cancer	0.000307	0.0004	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TP53—liver cancer	0.000306	0.000398	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—MYC—liver cancer	0.0003	0.000391	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HRAS—liver cancer	0.000292	0.000381	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—MAPK14—liver cancer	0.000283	0.000369	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IL6—liver cancer	0.00028	0.000364	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—ESR1—liver cancer	0.000278	0.000362	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AKT1—liver cancer	0.000258	0.000336	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—PPARG—liver cancer	0.000254	0.00033	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—SERPINE1—liver cancer	0.000228	0.000298	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—MYC—liver cancer	0.000145	0.000188	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—AKT1—liver cancer	0.0001	0.000131	CbGpPWpGaD
